As of 27 November 2024, you can find a table that includes information on ongoing and resolved medicine supply shortages that EMA assessed.
You can download data related to medicines published on EMA's website in table format. The website automatically updates these data tables overnight.
To stay up-to-date with new and updated information on this website, see:
Medicines
Find the following types of information on medicines in the table below:
- Approved medicines
- Withdrawn applications for new marketing authorisations
- Status of opinions
All relevant information and documents on medicines authorised at a European Union (EU) level are available onmedicine pages. This includes:
- Full scientific assessment reports
- Public-friendly overviews in question-and-answer format
- Package leaflets
These pages also contain information on medicines for which the European Commission has refused a marketing authorisation, or has suspended or withdrawn the marketing authorisation after approval.
More up-to-date information on veterinary medicinal products is available on theVeterinary Medicines Information website.
For more information, see:
Post-authorisation procedures for medicines
Find information on opinions onpost-authorisation procedures and withdrawn applications in the table below.
Download post-authorisation procedures for medicines data tableDuring thepost-authorisation stage of a medicine life-cycle, marketing authorisation holders can submit an application to change the terms of marketing authorisation. This is known as avariation.
At any stage of the assessment process, applicants can withdraw the application to EMA.
Information on approved post-authorisation procedures is available on medicine pages.
For more information, see:
Referrals
Find information on allongoing andcompleted referralsin the table below.
Download referrals data tableFor more information, see:
Paediatric investigation plans
Find information on decisions related topaediatric investigation plansfollowing evaluation from the Paediatric Committee (PDCO) in the table below.
Download paediatric investigation plans data tableFor more information, see:
Orphan designations
Find information on the status oforphan designationsfollowing assessment from the Committee for Orphan Medicinal Products (COMP) in the table below.
Download orphan designations data tableFor more information, see:
Periodic safety update report single assessments (PSUSAs)
Find information on the regulatory outcomes ofperiodic safety update reportsingle assessments (PSUSAs) in the table below.
Download period safety update report single assessments data tableMarketing authorisation holders periodically submit PSURs following a medicine's authorisation. EMA and national competent authorities carry out a single joint assessment of all medicines containing the same active substance or combination of active substances to determine if there is a need to update marketing authorisations.
For more information, see:
Direct healthcare professional communications (DHPCs)
Find information ondirect healthcare professional communication (DHPCs) for human and veterinary medicines in the table below. These contain important new safety information about a medicine, including recommended actions that healthcare professionals should take.
Download direct healthcare professional communications data tableMedicine supply shortages
Find information on ongoing and resolvedmedicine supply shortages assessed by EMA in the table below. The table includes links to individual shortage notices that contain valuable information for healthcare professionals and patients, along with details on the availability of alternatives.
Download medicine supply shortages data tableFor each shortage, additional information about the situation in a specific country may be available from the national competent authority.
For more information, see:
Herbal medicines
Find information on the status and outcomes of assessments from EMA's Committee on Herbal Medicinal Products (HMPC) in the table below.
Download herbal medicines data tableFor more information, see:
Medicines for use outside EU
Find information on the status of EMA's scientific opinions onhigh priority medicinesfor use outside of the EU in the table below.
Download medicines for use outside EU data tableFor more information, see:
EMA is making its entire website available in JSON format for automated use. For medicines and related procedures, the data provided is identical to that provided in the tables on this page.
Related documents
Product information URLs for member states
English (EN) (692 KB - XLS)